Literature DB >> 6236014

The effect of low doses of prednisolone on the traffic of T helper-inducer cells in rheumatoid arthritis.

G Verbruggen, E M Veys, P Hermanns, J Delanghe, M Vansteenkiste.   

Abstract

The effects of a single dose of 5 and 10 mg of prednisolone on the kinetics of lymphocytes and T lymphocyte subsets were investigated in patients suffering from active rheumatoid arthritis. Six hours after intake of 10 mg of the drug a significant drop in total lymphocyte count, total T-cell numbers and T-helper cell numbers was recorded. The values returned to baseline values within 24 hours. Intake of 5 mg of prednisolone depressed total T-cell count and more particularly the absolute numbers of T-helper cells. No statistically significant changes occurred in T suppressor-cytotoxic cell traffics. The influence on the kinetics of T-helper cells was responsible for a significant decrease of helper/suppressor ratios in the intravascular compartment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6236014     DOI: 10.1007/bf02042775

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

1.  The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes.

Authors:  B F Haynes; A S Fauci
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

2.  Fc-receptor heterogeneity of human suppressor T cells.

Authors:  A R Hayward; L Layward; P M Lydyard; L Moretta; M Dagg; A R Lawton
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

3.  Evidence for individual human peripheral blood lymphocytes bearing both B and T cell markers.

Authors:  H B Dickler; N F Adkinson; W D Terry
Journal:  Nature       Date:  1974-01-25       Impact factor: 49.962

4.  The binding of human IgG subclasses to human monocytes.

Authors:  F C Hay; G Torrigiani; I M Roitt
Journal:  Eur J Immunol       Date:  1972-06       Impact factor: 5.532

5.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

6.  Strategies for generating monoclonal antibodies defining human t-lymphocyte differentiation antigens.

Authors:  P C Kung; M A Talle; M E DeMaria; M S Butler; J Lifter; G Goldstein
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

7.  Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents.

Authors:  E M Veys; P Hermanns; G Goldstein; P Kung; J Schindler; J Van Wauwe
Journal:  Int J Immunopharmacol       Date:  1981

8.  Further characterization of the human inducer T cell subset defined by monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

9.  Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness.

Authors:  L Moretta; M Ferrarini; M C Mingari; A Moretta; S R Webb
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

10.  The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

View more
  3 in total

1.  Peripheral blood lymphocyte subsets in polymyalgia rheumatica.

Authors:  A Uddhammar; G Roos; B Näsman; S R Dahlqvist
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

Review 2.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

3.  Comparison of blood and synovial fluid lymphocyte subsets in rheumatoid arthritis and osteoarthritis.

Authors:  A Kuryliszyn-Moskal
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.